Editas Medicine, Inc. (NasdaqGS:EDIT) entered into purchase agreement to acquire certain assets from i2 Pharmaceuticals on January 7, 2018. Editas Medicine, Inc. (NasdaqGS:EDIT) completed the acquisition of certain assets from i2 Pharmaceuticals for $3.5 million on January 22, 2018. Under the terms of the transaction, Editas Medicine paid $1.6 million in cash and issued an aggregate of 56,099 shares of common stock, to i2 Pharmaceuticals, Inc.